Furthermore, LUAD patients with high NUSAP1 expression displayed a greater proportion of immune cells such as CD8+ T cells, activated CD4+ memory T cells, M0 and M1 macrophages, as well as augmented expression of ICB-relevant genes, significantly contributing to the facilitation of anti-cancer immune activity. This evidence concerns the gene NUSAP1 and cancer.